药明康德（02359）今日盘中股价大幅拉升，涨幅一度达到5.06%，成为市场关注的焦点。
消息面上，公司于前一日盘后发布了2025年年度业绩报告，多项核心财务指标创下历史新高。报告显示，2025年公司实现营业收入454.56亿元，同比增长15.8%；归母净利润达到191.51亿元，同比大幅增长102.65%。公司解释业绩增长主要得益于持续聚焦及加强CRDMO业务模式、优化生产工艺和经营效率，以及临床后期和商业化项目增长带来的产能效率提升。
与此同时，公司宣布了丰厚的股东回报计划，拟向全体股东每10股派发现金红利15.7927元（含税），合计派发约47.12亿元。公司还对2026年业绩给出了积极指引，预计整体收入将达到513亿元至530亿元，持续经营业务收入同比增长18%至22%。强劲的盈利能力、高额分红以及乐观的未来展望，共同提振了投资者信心，推动了股价在盘中的显著上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.